We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+9.23%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$325M
AUM Growth
Cap. Flow
+$311M
Cap. Flow %
95.96%
Top 10 Hldgs %
23.82%
Holding
94
New
93
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 21.71%
2 Consumer Discretionary 15.26%
3 Industrials 10.39%
4 Energy 7.87%
5 Technology 7.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PWR icon
51
Quanta Services
PWR
$98.7B
$2.5M 0.77%
+79,100
New +$2.32M
DWSN
52
DELISTED
DAWSON GEOPHYSICAL CO
DWSN
$2.21M 0.68%
+65,300
New +$2.04M
TSLA icon
53
Tesla
TSLA
$1.22T
$2.15M 0.66%
+214,500
New +$2.19M
SAAS
54
DELISTED
inContact, Inc.
SAAS
$1.51M 0.47%
+193,300
New +$1.47M
CTRA
55
DELISTED
Coterra Energy
CTRA
$1.36M 0.42%
+35,200
New +$1.26M
TTPH
56
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$1.31M 0.4%
+4,830
New +$1.15M
ATRC icon
57
AtriCure
ATRC
$2.04B
$1.29M 0.4%
+69,300
New +$1.01M
ININ
58
DELISTED
Interactive Intelligence Group, inc.
ININ
$1.01M 0.31%
+15,000
New +$961K
SHPG
59
DELISTED
Shire pic
SHPG
$904K 0.28%
+6,400
New +$841K
MDSO
60
DELISTED
Medidata Solutions, Inc.
MDSO
$848K 0.26%
+14,000
New +$776K
CBST
61
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
$820K 0.25%
+11,900
New +$770K
XOMA
62
DELISTED
Xoma
XOMA
$818K 0.25%
+6,080
New +$613K
SLXP
63
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
$809K 0.25%
+9,000
New +$718K
CEMP
64
DELISTED
Cempra, Inc.
CEMP
$797K 0.25%
+64,300
New +$778K
CSII
65
DELISTED
Cardiovascular Systems, Inc.
CSII
$782K 0.24%
+22,800
New +$663K
PCRX icon
66
Pacira BioSciences
PCRX
$1.06B
$765K 0.24%
+13,300
New +$699K
RGEN icon
67
Repligen
RGEN
$7.03B
$732K 0.23%
+53,700
New +$641K
BMRN icon
68
BioMarin Pharmaceuticals
BMRN
$11.7B
$731K 0.23%
+10,400
New +$706K
AMBI
69
DELISTED
Ambit Biosciences Corp
AMBI
$714K 0.22%
+74,100
New +$989K
NTUS
70
DELISTED
Natus Medical Inc
NTUS
$693K 0.21%
+30,800
New +$595K
KPTI icon
71
Karyopharm Therapeutics
KPTI
$159M
$678K 0.21%
+1,973
New +$545K
OMED
72
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$664K 0.2%
+22,500
New +$412K
CERS icon
73
Cerus
CERS
$579M
$631K 0.19%
+97,800
New +$614K
HPTX
74
DELISTED
HYPERION THERAPEUTICS INC COM STK (DE)
HPTX
$631K 0.19%
+31,200
New +$734K
BRKR icon
75
Bruker
BRKR
$9.79B
$605K 0.19%
+30,600
New +$600K

Similar funds

Eventide Asset Management's Q4 2013 Portfolio in Review

Q4 2013 is the first quarter with a 13F filing on record for Eventide Asset Management, which disclosed 94 positions worth $325M. Its ten largest holdings account for 24% of the portfolio.

Its largest position is MEDIVATION, INC.: 269,600 shares worth $8.6M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, followed by Consumer Discretionary and Industrials.

  • Eventide Asset Management's largest Q4 2013 buy was MEDIVATION, INC.: 269,600 shares worth $8.6M.
  • Eventide Asset Management's ten largest holdings make up 24% of its $325M portfolio in Q4 2013.
  • Eventide Asset Management disclosed 94 positions in Q4 2013, its first 13F filing on record.

Based on Eventide Asset Management's 13F filing for Q4 2013, filed 11 Feb 2014.